Ann: ResApp Provides Australian Adult Study Enrolment Update-RAP.AX, page-28

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 28 Last

Share
Profile

Follow
Dr x

43 Posts.

07/06/16

10:38

Post #: 17969691
Share

Originally posted by Larry73 ↑

ResApp Health Limited (ASX: RAP), the developer of smartphone medical applications for the diagnosis and management of respiratory disease, today announced that it has enrolled 322 adult patients (236 confirmed respiratory disease cases and 86 control cases) in its first adult study at Joondalup Health Campus. - That is an accuracy of 80% successful diagnosis, while the other 20% were identified and controlled. Incredible.

Enrolment at the Wesley Emergency Centre in Brisbane, Australia has recently started which will significantly increase the rate of enrolment and greatly expand the range of respiratory illnesses captured.

The study at the Wesley Emergency Centre is also ResApp’s first clinical site to perform electronic data collection using Apple iPads which will increase the speed of data verification and analysis. “We are very pleased with the rate of patient enrolment at Joondalup.

At that one site we are already close to achieving our initial target total enrolment of 400 adult patients and with the Wesley also recruiting patients we expect to exceed our initial target shortly,” said Dr Tony Keating, Managing Director and CEO of ResApp. “We are now looking towards the first preliminary analysis of the adult data which is on track to be released by the end of this quarter.”

This was also lovely to read:
WEC’s Director of Emergency Medicine Dr Sean Rothwell said the WEC, which was one of the biggest private emergency centres in the country, was happy to participate in the trial as it could have huge healthcare benefits. It has the potential to become an efficient diagnostic tool for emergency centres around the country and the world, he said.

Great times ahead, this month is going to be huge

Expand

I think you've misinterpreted the control bit. Control cases aren't cases that are controlled - they are people who don't have the disease that have to be included in the trial in order to have a baseline or 'control' to test the successfulness of the trial. Therefore there are 236 individuals WITH the disease and 86 without, and they will use the app to test all of them in order to see if the app can successfully diagnose all those WITH the the disease, and successfully rule out those without

RAP Price at posting: 38.5¢ Sentiment: Hold Disclosure: Held
22 Upvote

0 Great analysis

Reply

Top Stories

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

SXG

Southern Cross finds large gold-antimony zone underneath historic Victorian mine

DEL

Delorean unlocks $30M through Tanarra finance facility for bioenergy projects

TPG

ACCC says no issue with TPG Telecom and Optus Mobile sharing regional networks; spectrum

ADH

Adairs MD and CEO steps down after 17 years in company management